Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment

Documenti analoghi

• Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in Pancreatic Cancer: A Systematic Review
  di: Hanye Sohrabi, et al.
  Pubblicazione: (2026)
• Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden‐High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment
  di: Yugo Kai, et al.
  Pubblicazione: (2026)
• Correlation Between Treatment‐Related Adverse Events and Efficacy of Camrelizumab in Combination With Apatinib in Patients With Unresectable Hepatocellular Carcinoma
  di: Ting Zhang, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Low‐Dose Oral Etoposide Combined With Capecitabine for Patients With Postoperative Metastatic Breast Cancer Resistant to Anthracycline/Taxanes
  di: Xue Chen, et al.
  Pubblicazione: (2025)
• Structured Exercise During Chemotherapy for Locally Advanced or Metastatic Pancreatic Cancer: A Single‐Arm, Feasibility Trial
  di: Anita Borsati, et al.
  Pubblicazione: (2026)